Advertisement
Screener

VERU INC. (VERU) Treasury Stock, Shares, Acquired

2.8 / 5 stars · 68/120 Roast Me

VERU INC. Treasury Stock, Shares, Acquired

Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).

  • VERU INC. treasury stock, shares, acquired for the quarter ending 2016-03-31 was 0.00 shares, a 100.00% decline year-over-year.
  • VERU INC. treasury stock, shares, acquired for the quarter ending 2015-12-31 was 0.00 shares.
  • VERU INC. treasury stock, shares, acquired for the quarter ending 2015-09-30 was 0.00 shares, a 100.00% decline year-over-year.
  • VERU INC. treasury stock, shares, acquired for the quarter ending 2015-06-30 was 0.00 shares, a 100.00% decline year-over-year.
  • VERU INC. treasury stock, shares, acquired for fiscal 2015 was 250.00 shares, a 99.85% decline from fiscal 2014.
  • VERU INC. treasury stock, shares, acquired for fiscal 2014 was 169.00K shares, a 203.82% increase from fiscal 2013.
  • VERU INC. treasury stock, shares, acquired for fiscal 2013 was 55.63K shares, a 26.42% increase from fiscal 2012.
  • VERU INC. treasury stock, shares, acquired for fiscal 2012 was 44.00K shares.
Period endTreasury Stock, Shares, Acquired 3 monthTreasury Stock, Shares, Acquired 12 month
2016-03-310.00 shares
derived: 10-Q 111 month − 10-Q 108 month · filed 2016-04-28
0.00 shares
derived: sum of 4 quarters · filed 2018-01-02
2015-12-310.00 shares
derived: 10-Q 108 month − 10-Q 105 month · filed 2016-02-02
250.00 shares
derived: sum of 4 quarters · filed 2018-01-02
2015-09-300.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-02
250.00 shares
10-K · filed 2018-01-02
2015-06-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-07-30
132.75K shares
derived: sum of 4 quarters · filed 2016-12-12
2015-03-31250.00 shares
10-Q · filed 2015-07-30
167.75K shares
derived: sum of 4 quarters · filed 2016-12-12
2014-12-310.00 shares
derived: 10-Q 96 month − 10-Q 93 month · filed 2015-02-03
169.00K shares
derived: sum of 4 quarters · filed 2016-12-12
2014-09-30132.50K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12
169.00K shares
10-K · filed 2016-12-12
2014-06-3035.00K shares
10-Q · filed 2014-07-31
39.00K shares
derived: sum of 4 quarters · filed 2015-12-02
2014-03-311.50K shares
10-Q · filed 2014-07-31
4.00K shares
derived: sum of 4 quarters · filed 2015-12-02
2013-12-310.00 shares
derived: 10-Q 84 month − 10-Q 81 month · filed 2014-02-03
55.63K shares
derived: sum of 4 quarters · filed 2015-12-02
2013-09-302.50K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-02
55.63K shares
10-K · filed 2015-12-02
2013-06-300.00 shares
derived: 10-Q 78 month − 10-Q 75 month · filed 2013-08-01
112.13K shares
derived: sum of 4 quarters · filed 2014-12-02
2013-03-3153.13K shares
derived: 10-Q 75 month − 10-K 72 month · filed 2013-05-02
2012-12-3125.00K shares
10-Q · filed 2013-01-30
2012-09-3034.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-02
44.00K shares
10-K · filed 2014-12-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kairos Pharma, LTD. (KAPA)United States$0.041B
SCYNEXIS INC (SCYX)United States$0.045B
PDS Biotechnology Corp (PDSB)United States$0.045B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Edesa Biotech, Inc. (EDSA)Canada$0.039B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
CervoMed Inc. (CRVO)United States$0.038B-1.39
Celularity Inc (CELU)United States$0.038B-0.34